Corebridge Financial, Inc. (NYSE:CRBG) ("Corebridge" or the "Company") today announced that its Board of Directors has declared a special dividend of $0.62 per share payable on June 30,

AIG

Arimoclomol and Aldoxorubicin Acquisition to Bolster XOMA’s Revenue Growth: Analyst

By Vandana Singh

June 22, 3:09 PM

Earlier today, XOMA Corporation (NASDAQ: XOMA) acquired the royalty and milestone rights associated with two assets from LadRx Corporation: arimoclomol for Niemann-Pick disease type C, and aldoxorubicin, an albumin-linked formulation of doxorubicin

XOMA

What’s Going On With Connexa Sports Technologies Stock?

By Erica Kollmann

January 31, 1:53 PM

According to an SEC filing, on Jan.19, Connexa Sports Technologies entered into securities purchase agreements with three investors for the issuance and sale to each investor of 2,330,200 shares of common stock and pre-funded warrants to purchase an aggregate of 25,169,800 shares of its common stock at a combined purchase price of $0.20 per share of the common stock for an aggregate amount of approximately $16.5 million.

CNXA

Zacks Small-Cap Research Sets $15 Valuation On Edesa Biotech

Related Posts

Analyst Expectations for Element Solutions’s Future

Corebridge Financial Declares Special Dividend Of $0.62 Per Share

Arimoclomol and Aldoxorubicin Acquisition to Bolster XOMA’s Revenue Growth: Analyst

What’s Going On With Connexa Sports Technologies Stock?